{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:31:36Z","timestamp":1793068296098,"version":"4.5.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00432-020-03152-7","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T09:02:50Z","timestamp":1582016570000},"page":"909-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Volume de-escalation in radiation therapy: state of the art and new perspectives"],"prefix":"10.1007","volume":"146","author":[{"name":"AIRO Giovani -Italian Association of Radiation Oncology-Young Members","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Meduri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Gregucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5954-0939","authenticated-orcid":false,"given":"Elisa","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Alitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ciurlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isacco","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Borghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"3152_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.radonc.2012.12.006","volume":"106","author":"A Al-Mamgani","year":"2013","unstructured":"Al-Mamgani A, van Rooij P, Fransen D, Levendag P (2013) Unilateral neck irradiation for well-lateralized oropharyngeal cancer. Radiother Oncol 106:69\u201373. https:\/\/doi.org\/10.1016\/j.radonc.2012.12.006","journal-title":"Radiother Oncol"},{"key":"3152_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ctrv.2017.07.004","volume":"59","author":"A Al-Mamgani","year":"2017","unstructured":"Al-Mamgani A et al (2017) Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: a literature-based critical review. Cancer Treat Rev 59:102\u2013108. https:\/\/doi.org\/10.1016\/j.ctrv.2017.07.004","journal-title":"Cancer Treat Rev"},{"key":"3152_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00432-018-2781-7","volume":"145","author":"F Alongi","year":"2019","unstructured":"Alongi F et al (2019) First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc) for Linac-based VMAT radiosurgery in brain metastases. J Cancer Res Clin Oncol 145:193\u2013200. https:\/\/doi.org\/10.1007\/s00432-018-2781-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"3152_CR4","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","volume":"35","author":"MPE Andre","year":"2017","unstructured":"Andre MPE et al (2017) Early positron emission tomography response-adapted treatment in stage I and Ii Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 Trial. J Clin Oncol 35:1786\u20131794. https:\/\/doi.org\/10.1200\/JCO.2016.68.6394","journal-title":"J Clin Oncol"},{"key":"3152_CR5","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665\u20131672. https:\/\/doi.org\/10.1016\/S0140-6736(04)16250-8","journal-title":"Lancet"},{"key":"3152_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24\u201335. https:\/\/doi.org\/10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"key":"3152_CR7","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA J Am Med Assoc 295:2483\u20132491. https:\/\/doi.org\/10.1001\/jama.295.21.2483","journal-title":"JAMA J Am Med Assoc"},{"key":"3152_CR8","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/hed.25587","volume":"41","author":"S Baker","year":"2019","unstructured":"Baker S, Verduijn G, Petit S, Nuyttens JJ, Sewnaik A, van der Lugt A, Heemsbergen WD (2019) Locoregional failures and their relation to radiation fields following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma. Head Neck 41:1622\u20131631. https:\/\/doi.org\/10.1002\/hed.25587","journal-title":"Head Neck"},{"key":"3152_CR9","doi-asserted-by":"crossref","unstructured":"Barrington SF et al. (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32:3048\u20133058 doi:10.1200\/JCO.2013.53.5229","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"3152_CR10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ijrobp.2005.08.035","volume":"64","author":"AK Bhatnagar","year":"2006","unstructured":"Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD (2006) Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 64:898\u2013903. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.08.035","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.radonc.2014.11.043","volume":"114","author":"MI Bittner","year":"2015","unstructured":"Bittner MI, Grosu AL, Brunner TB (2015) Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer - a systematic review. Radiother Oncol 114:117\u2013121. https:\/\/doi.org\/10.1016\/j.radonc.2014.11.043","journal-title":"Radiother Oncol"},{"key":"3152_CR12","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00432-017-2419-1","volume":"143","author":"A Bottcher","year":"2017","unstructured":"Bottcher A et al (2017) A novel classification scheme for advanced laryngeal cancer midline involvement: implications for the contralateral neck. J Cancer Res Clin Oncol 143:1605\u20131612. https:\/\/doi.org\/10.1007\/s00432-017-2419-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"3152_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA J Am Med Assoc 316:401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA J Am Med Assoc"},{"key":"3152_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","volume":"36","author":"PD Brown","year":"2018","unstructured":"Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V (2018) Whole-brain radiotherapy for brain metastases: evolution or revolution? J Clin Oncol 36:483\u2013491. https:\/\/doi.org\/10.1200\/JCO.2017.75.9589","journal-title":"J Clin Oncol"},{"key":"3152_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/1097-0347(200007)22:4%3c380::aid-hed11%3e3.0.co;2-e","volume":"22","author":"JG Buckley","year":"2000","unstructured":"Buckley JG, MacLennan K (2000) Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 22:380\u2013385. https:\/\/doi.org\/10.1002\/1097-0347(200007)22:4%3c380:aid-hed11%3e3.0.co;2-e","journal-title":"Head Neck"},{"key":"3152_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.oraloncology.2019.03.013","volume":"92","author":"AR Burr","year":"2019","unstructured":"Burr AR, Harari PM, Ko HC, Bruce JY, Kimple RJ, Witek ME (2019) Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer. Oral Oncol 92:52\u201356. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.03.013","journal-title":"Oral Oncol"},{"key":"3152_CR17","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1200\/JCO.2007.15.1001","volume":"26","author":"BA Campbell","year":"2008","unstructured":"Campbell BA, Voss N, Pickles T, Morris J, Gascoyne RD, Savage KJ, Connors JM (2008) Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size. J Clin Oncol 26:5170\u20135174. https:\/\/doi.org\/10.1200\/JCO.2007.15.1001","journal-title":"J Clin Oncol"},{"key":"3152_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/cncr.24059","volume":"115","author":"DT Chang","year":"2009","unstructured":"Chang DT et al (2009) Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 115:665\u2013672. https:\/\/doi.org\/10.1002\/cncr.24059","journal-title":"Cancer"},{"key":"3152_CR19","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037\u20131044. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"issue":"Suppl","key":"3152_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/2010.8.GKS10994","volume":"113","author":"WS Chang","year":"2010","unstructured":"Chang WS, Kim HY, Chang JW, Park YG, Chang JH (2010) Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg 113(Suppl):73\u201378. https:\/\/doi.org\/10.3171\/2010.8.GKS10994","journal-title":"J Neurosurg"},{"key":"3152_CR21","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1002\/cncr.30931","volume":"123","author":"RI Chin","year":"2017","unstructured":"Chin RI et al (2017) Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil. Cancer 123:4594\u20134607. https:\/\/doi.org\/10.1002\/cncr.30931","journal-title":"Cancer"},{"key":"3152_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/archotol.1989.01860320091025","volume":"115","author":"JM Chow","year":"1989","unstructured":"Chow JM, Levin BC, Krivit JS, Applebaum EL (1989) Radiotherapy or surgery for subclinical cervical node metastases. Archives of Otolaryngol Head Neck Surg 115:981\u2013984. https:\/\/doi.org\/10.1001\/archotol.1989.01860320091025","journal-title":"Archives of Otolaryngol Head Neck Surg"},{"key":"3152_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijrobp.2011.06.1975","volume":"83","author":"GM Chronowski","year":"2012","unstructured":"Chronowski GM et al (2012) Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys 83:204\u2013209. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.06.1975","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijrobp.2013.02.022","volume":"86","author":"MD Chuong","year":"2013","unstructured":"Chuong MD et al (2013) Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Int J Radiat Oncol Biol Phys 86:516\u2013522. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.02.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR25","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/s0140-6736(17)31145-5","volume":"390","author":"CE Coles","year":"2017","unstructured":"Coles CE et al (2017) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. The Lancet 390:1048\u20131060. https:\/\/doi.org\/10.1016\/s0140-6736(17)31145-5","journal-title":"The Lancet"},{"key":"3152_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/1533034616650778","volume":"16","author":"T Comito","year":"2017","unstructured":"Comito T et al (2017) Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a Phase 2 Study. Technol Cancer Rese Treat 16:295\u2013301. https:\/\/doi.org\/10.1177\/1533034616650778","journal-title":"Technol Cancer Rese Treat"},{"key":"3152_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijrobp.2016.10.004","volume":"97","author":"JL Conway","year":"2017","unstructured":"Conway JL et al (2017) Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 97:35\u201341. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.10.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","volume":"7","author":"C Correa","year":"2017","unstructured":"Correa C et al (2017) Accelerated Partial Breast Irradiation: executive summary for the update of an ASTRO Evidence-Based Consensus Statement. Pract Radiat Oncol 7:73\u201379. https:\/\/doi.org\/10.1016\/j.prro.2016.09.007","journal-title":"Pract Radiat Oncol"},{"key":"3152_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.oraloncology.2015.03.013","volume":"51","author":"TD Dan","year":"2015","unstructured":"Dan TD et al (2015) Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach. Oral Oncol 51:616\u2013621. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.03.013","journal-title":"Oral Oncol"},{"key":"3152_CR30","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/s0360-3016(99)00550-7","volume":"46","author":"LA Dawson","year":"2000","unstructured":"Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, Eisbruch A (2000) Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46:1117\u20131126. https:\/\/doi.org\/10.1016\/s0360-3016(99)00550-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/bjh.15623","volume":"184","author":"J Depaus","year":"2019","unstructured":"Depaus J, Delcourt A, Andre M (2019) Therapeutic recommendations for early stage Hodgkin lymphomas. Br J Haematol 184:9\u201316. https:\/\/doi.org\/10.1111\/bjh.15623","journal-title":"Br J Haematol"},{"key":"3152_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","volume":"111","author":"AK Due","year":"2014","unstructured":"Due AK et al (2014) Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol 111:360\u2013365. https:\/\/doi.org\/10.1016\/j.radonc.2014.06.001","journal-title":"Radiother Oncol"},{"key":"3152_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41571-018-0048-5","volume":"15","author":"AMM Eggermont","year":"2018","unstructured":"Eggermont AMM, Robert C, Ribas A (2018) The new era of adjuvant therapies for melanoma. Nat Rev Clin Oncol 15:535\u2013536. https:\/\/doi.org\/10.1038\/s41571-018-0048-5","journal-title":"Nat Rev Clin Oncol"},{"key":"3152_CR34","doi-asserted-by":"publisher","first-page":"iV19","DOI":"10.1093\/annonc\/mdy080","volume":"29","author":"DA Eichenauer","year":"2018","unstructured":"Eichenauer DA et al (2018) Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iV19\u2013iv29. https:\/\/doi.org\/10.1093\/annonc\/mdy080","journal-title":"Ann Oncol"},{"key":"3152_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbcan.2014.12.001","volume":"1855","author":"E Fokas","year":"2015","unstructured":"Fokas E, O'Neill E, Gordon-Weeks A, Mukherjee S, McKenna WG, Muschel RJ (2015) Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic. Biochem Biophys Acta 1855:61\u201382. https:\/\/doi.org\/10.1016\/j.bbcan.2014.12.001","journal-title":"Biochem Biophys Acta"},{"key":"3152_CR36","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1200\/JCO.19.00964","volume":"37","author":"M Fuchs","year":"2019","unstructured":"Fuchs M et al (2019) Positron emission tomography-guided treatment in early-stage favorable Hodgkin Lymphoma: final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group. J Clin Oncol 37:2835\u20132845. https:\/\/doi.org\/10.1200\/JCO.19.00964","journal-title":"J Clin Oncol"},{"key":"3152_CR37","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1182\/blood-2015-05-647412","volume":"126","author":"S Giri","year":"2015","unstructured":"Giri S, Pathak R, Martin MG, Bhatt VR (2015) Incidence of breast cancer among female survivors of Hodgkin lymphoma: a US-population-based trend analysis from 1973 to 2011. Blood 126:1861\u20131863. https:\/\/doi.org\/10.1182\/blood-2015-05-647412","journal-title":"Blood"},{"key":"3152_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","volume":"79","author":"T Girinsky","year":"2006","unstructured":"Girinsky T et al (2006) Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79:270\u2013277. https:\/\/doi.org\/10.1016\/j.radonc.2006.05.015","journal-title":"Radiother Oncol"},{"key":"3152_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.radonc.2008.05.012","volume":"88","author":"T Girinsky","year":"2008","unstructured":"Girinsky T et al (2008) The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiother Oncol 88:202\u2013210. https:\/\/doi.org\/10.1016\/j.radonc.2008.05.012","journal-title":"Radiother Oncol"},{"key":"3152_CR40","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.ijrobp.2014.04.026","volume":"89","author":"T Girinsky","year":"2014","unstructured":"Girinsky T et al (2014) Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients. Int J Radiat Oncol Biol Phys 89:1047\u20131052. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.04.026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jss.2011.07.044","volume":"174","author":"K Goyal","year":"2012","unstructured":"Goyal K et al (2012) Stereotactic body radiation therapy for nonresectable tumors of the pancreas. J Surg Res 174:319\u2013325. https:\/\/doi.org\/10.1016\/j.jss.2011.07.044","journal-title":"J Surg Res"},{"key":"3152_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1748-717X-8-44","volume":"8","author":"MK Gurka","year":"2013","unstructured":"Gurka MK et al (2013) Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety. Radiat Oncol 8:44. https:\/\/doi.org\/10.1186\/1748-717X-8-44","journal-title":"Radiat Oncol"},{"key":"3152_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/COC.0000000000000118","volume":"40","author":"MK Gurka","year":"2017","unstructured":"Gurka MK et al (2017) Stereotactic body radiation therapy (SBRT) combined with chemotherapy for unresected pancreatic adenocarcinoma. Am J Clin Oncol 40:152\u2013157. https:\/\/doi.org\/10.1097\/COC.0000000000000118","journal-title":"Am J Clin Oncol"},{"key":"3152_CR44","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/cncr.30009","volume":"122","author":"LM Halasz","year":"2016","unstructured":"Halasz LM et al (2016) Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. Cancer 122:2091\u20132100. https:\/\/doi.org\/10.1002\/cncr.30009","journal-title":"Cancer"},{"key":"3152_CR45","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1001\/jama.2016.4324","volume":"315","author":"P Hammel","year":"2016","unstructured":"Hammel P et al (2016) Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA J Am Med Assoc 315:1844\u20131853. https:\/\/doi.org\/10.1001\/jama.2016.4324","journal-title":"JAMA J Am Med Assoc"},{"key":"3152_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.radonc.2017.11.004","volume":"126","author":"TP Hanna","year":"2018","unstructured":"Hanna TP, Shafiq J, Delaney GP, Vinod SK, Thompson SR, Barton MB (2018) The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits. Radiother Oncol 126:191\u2013197. https:\/\/doi.org\/10.1016\/j.radonc.2017.11.004","journal-title":"Radiother Oncol"},{"key":"3152_CR47","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS et al (2013) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14:1086\u20131094. https:\/\/doi.org\/10.1016\/S1470-2045(13)70386-3","journal-title":"Lancet Oncol"},{"key":"3152_CR48","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/cncr.29161","volume":"121","author":"JM Herman","year":"2015","unstructured":"Herman JM et al (2015) Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer 121:1128\u20131137. https:\/\/doi.org\/10.1002\/cncr.29161","journal-title":"Cancer"},{"key":"3152_CR49","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.radonc.2010.01.017","volume":"97","author":"KF Ho","year":"2010","unstructured":"Ho KF, Farnell DJ, Routledge JA, Burns MP, Sykes AJ, Slevin NJ, Davidson SE (2010) Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy. Radiother Oncol 97:270\u2013275. https:\/\/doi.org\/10.1016\/j.radonc.2010.01.017","journal-title":"Radiother Oncol"},{"key":"3152_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.022","volume":"76","author":"M Hoyer","year":"2005","unstructured":"Hoyer M et al (2005) Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 76:48\u201353. https:\/\/doi.org\/10.1016\/j.radonc.2004.12.022","journal-title":"Radiother Oncol"},{"key":"3152_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0167-8140(99)00051-1","volume":"51","author":"SM Jackson","year":"1999","unstructured":"Jackson SM, Hay JH, Flores AD, Weir L, Wong FL, Schwindt C, Baerg B (1999) Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol 51:123\u2013128. https:\/\/doi.org\/10.1016\/s0167-8140(99)00051-1","journal-title":"Radiother Oncol"},{"key":"3152_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.radonc.2007.06.005","volume":"85","author":"K Jensen","year":"2007","unstructured":"Jensen K, Overgaard M, Grau C (2007) Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiother Oncol 85:90\u201397. https:\/\/doi.org\/10.1016\/j.radonc.2007.06.005","journal-title":"Radiother Oncol"},{"key":"3152_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0167-8140(99)00179-6","volume":"54","author":"K Kagei","year":"2000","unstructured":"Kagei K et al (2000) Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol 54:117\u2013121. https:\/\/doi.org\/10.1016\/s0167-8140(99)00179-6","journal-title":"Radiother Oncol"},{"key":"3152_CR54","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00405-015-3725-3","volume":"273","author":"WR Kennedy","year":"2016","unstructured":"Kennedy WR et al (2016) Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Eur Arch Otorhinolaryngol 273:2151\u20132156. https:\/\/doi.org\/10.1007\/s00405-015-3725-3","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3152_CR55","doi-asserted-by":"crossref","unstructured":"Kocher M et al. (2014) Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al] 190:521\u2013532 doi:10.1007\/s00066\u2013014\u20130648\u20137","DOI":"10.1007\/s00066-014-0648-7"},{"key":"3152_CR56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29:134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2010.30.1655","journal-title":"J Clin Oncol"},{"key":"3152_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3857\/roj.2013.31.2.66","volume":"31","author":"TR Koo","year":"2013","unstructured":"Koo TR, Wu HG (2013) Long-term results of ipsilateral radiotherapy for tonsil cancer. Radiat Oncol J 31:66\u201371. https:\/\/doi.org\/10.3857\/roj.2013.31.2.66","journal-title":"Radiat Oncol J"},{"key":"3152_CR58","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ijrobp.2003.11.004","volume":"58","author":"AC Koong","year":"2004","unstructured":"Koong AC et al (2004) Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58:1017\u20131021. https:\/\/doi.org\/10.1016\/j.ijrobp.2003.11.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR59","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ijrobp.2015.12.003","volume":"94","author":"S Krishnan","year":"2016","unstructured":"Krishnan S et al (2016) Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation. Int J Radiat Oncol Biol Phys 94:755\u2013765. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.12.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR60","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","volume":"18","author":"B Lacas","year":"2017","unstructured":"Lacas B et al (2017) Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol 18:1221\u20131237. https:\/\/doi.org\/10.1016\/S1470-2045(17)30458-8","journal-title":"Lancet Oncol"},{"key":"3152_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2018.01.067","volume":"93","author":"A Levy","year":"2018","unstructured":"Levy A et al (2018) Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. Eur J Cancer 93:37\u201346. https:\/\/doi.org\/10.1016\/j.ejca.2018.01.067","journal-title":"Eur J Cancer"},{"key":"3152_CR62","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","volume":"363","author":"D Li","year":"2004","unstructured":"Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363:1049\u20131057. https:\/\/doi.org\/10.1016\/S0140-6736(04)15841-8","journal-title":"Lancet"},{"key":"3152_CR63","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","volume":"33","author":"X Lin","year":"2015","unstructured":"Lin X, DeAngelis LM (2015) Treatment of brain metastases. J Clin Oncol 33:3475\u20133484. https:\/\/doi.org\/10.1200\/JCO.2015.60.9503","journal-title":"J Clin Oncol"},{"key":"3152_CR64","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MEG.0000000000000283","volume":"27","author":"JC Lin","year":"2015","unstructured":"Lin JC, Jen YM, Li MH, Chao HL, Tsai JT (2015) Comparing outcomes of stereotactic body radiotherapy with intensity-modulated radiotherapy for patients with locally advanced unresectable pancreatic cancer. Eur J Gastroenterol Hepatol 27:259\u2013264. https:\/\/doi.org\/10.1097\/MEG.0000000000000283","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3152_CR65","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/hed.23297","volume":"36","author":"C Liu","year":"2014","unstructured":"Liu C, Dutu G, Peters LJ, Rischin D, Corry J (2014) Tonsillar cancer: the Peter MacCallum experience with unilateral and bilateral irradiation. Head Neck 36:317\u2013322. https:\/\/doi.org\/10.1002\/hed.23297","journal-title":"Head Neck"},{"key":"3152_CR66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","volume":"51","author":"L Livi","year":"2015","unstructured":"Livi L et al (2015) Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer 51:451\u2013463. https:\/\/doi.org\/10.1016\/j.ejca.2014.12.013","journal-title":"Eur J Cancer"},{"key":"3152_CR67","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.oraloncology.2014.06.019","volume":"50","author":"J Lynch","year":"2014","unstructured":"Lynch J, Lal P, Schick U, Nutting CM, Newbold K, Harrington K, Bhide S (2014) Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Oral Oncol 50:901\u2013906. https:\/\/doi.org\/10.1016\/j.oraloncology.2014.06.019","journal-title":"Oral Oncol"},{"key":"3152_CR68","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","volume":"26","author":"M Machtay","year":"2008","unstructured":"Machtay M et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582\u20133589. https:\/\/doi.org\/10.1200\/JCO.2007.14.8841","journal-title":"J Clin Oncol"},{"key":"3152_CR69","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1016\/j.ijrobp.2011.04.045","volume":"81","author":"A Mahadevan","year":"2011","unstructured":"Mahadevan A et al (2011) Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 81:e615\u2013622. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.04.045","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR70","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ijrobp.2012.08.041","volume":"85","author":"MV Maraldo","year":"2013","unstructured":"Maraldo MV, Aznar MC, Vogelius IR, Petersen PM, Specht L (2013) Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma. Int J Radiat Oncol Biol Phys 85:1057\u20131065. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.08.041","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR71","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00066-018-1306-2","volume":"194","author":"R Mazzola","year":"2018","unstructured":"Mazzola R et al (2018) Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery. Strahlenther Onkol 194:835\u2013842","journal-title":"Strahlenther Onkol"},{"key":"3152_CR72","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.1016\/S0167-8140(17)31008-3","volume":"123","author":"B Meduri","year":"2017","unstructured":"Meduri B, Baldissera A, Galeandro M, Donini E (2017) Accelerated PBI vs standard radiotherapy (IRMA-trial): interim cosmetic and toxicity results. Radiother Oncol 123:S303","journal-title":"Radiother Oncol"},{"key":"3152_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijrobp.2005.05.023","volume":"63","author":"MP Mehta","year":"2005","unstructured":"Mehta MP et al (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63:37\u201346. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.05.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"3152_CR74","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3109\/0284186X.2015.1004367","volume":"54","author":"EA Mellon","year":"2015","unstructured":"Mellon EA et al (2015) Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma. Acta Oncol 54(7):979\u2013985","journal-title":"Acta Oncol"},{"key":"3152_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hed.2890030105","volume":"3","author":"WM Mendenhall","year":"1980","unstructured":"Mendenhall WM, Million RR, Cassisi NJ (1980) Elective neck irradiation in squamous-cell carcinoma of the head and neck. Head Neck Surg 3:15\u201320. https:\/\/doi.org\/10.1002\/hed.2890030105","journal-title":"Head Neck Surg"},{"issue":"Suppl","key":"3152_CR76","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3171\/jns.2005.102.s_supplement.0147","volume":"102","author":"TK Nam","year":"2005","unstructured":"Nam TK et al (2005) Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors. J Neurosurg 102(Suppl):147\u2013150. https:\/\/doi.org\/10.3171\/jns.2005.102.s_supplement.0147","journal-title":"J Neurosurg"},{"key":"3152_CR77","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1200\/JCO.2013.50.5511","volume":"31","author":"IA Olivotto","year":"2013","unstructured":"Olivotto IA et al (2013) Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol 31:4038\u20134045. https:\/\/doi.org\/10.1200\/JCO.2013.50.5511","journal-title":"J Clin Oncol"},{"key":"3152_CR78","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/s0360-3016(01)01613-3","volume":"51","author":"B O'Sullivan","year":"2001","unstructured":"O'Sullivan B et al (2001) The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 51:332\u2013343. https:\/\/doi.org\/10.1016\/s0360-3016(01)01613-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR79","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ijrobp.2013.09.012","volume":"87","author":"P Passoni","year":"2013","unstructured":"Passoni P et al (2013) Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study. Int J Radiat Oncol Biol Phys 87:1000\u20131006. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.09.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR80","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s0305-7372(03)00105-1","volume":"29","author":"RA Patchell","year":"2003","unstructured":"Patchell RA (2003) The management of brain metastases. Cancer Treat Rev 29:533\u2013540. https:\/\/doi.org\/10.1016\/s0305-7372(03)00105-1","journal-title":"Cancer Treat Rev"},{"key":"3152_CR81","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494\u2013500. https:\/\/doi.org\/10.1056\/NEJM199002223220802","journal-title":"N Engl J Med"},{"key":"3152_CR82","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.ijrobp.2011.05.015","volume":"82","author":"A Paumier","year":"2012","unstructured":"Paumier A et al (2012) Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 82:1522\u20131527. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.05.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR83","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ijrobp.2014.12.040","volume":"91","author":"D Peterson","year":"2015","unstructured":"Peterson D et al (2015) Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis. Int J Radiat Oncol Biol Phys 91:968\u2013976. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.12.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR84","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC","year":"2009","unstructured":"Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4\u201314. https:\/\/doi.org\/10.1016\/j.radonc.2009.04.014","journal-title":"Radiother Oncol"},{"key":"3152_CR85","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ijrobp.2014.06.066","volume":"90","author":"EL Pollom","year":"2014","unstructured":"Pollom EL et al (2014) Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. Int J Radiat Oncol Biol Phys 90:918\u2013925. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.06.066","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"3152_CR86","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1245\/s10434-010-1019-y","volume":"17","author":"F Polistina","year":"2010","unstructured":"Polistina F et al (2010) Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. Ann Surg Oncol 17(8):2092\u20132101","journal-title":"Ann Surg Oncol"},{"key":"3152_CR87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/hed.24541","volume":"39","author":"TP Rackley","year":"2017","unstructured":"Rackley TP, Namelo WC, Palaniappan N, Cole N, Owens DM, Evans M (2017) Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil. Head Neck 39:17\u201323. https:\/\/doi.org\/10.1002\/hed.24541","journal-title":"Head Neck"},{"key":"3152_CR88","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijrobp.2012.02.042","volume":"85","author":"SA Raktoe","year":"2013","unstructured":"Raktoe SA, Dehnad H, Raaijmakers CP, Braunius W, Terhaard CH (2013) Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 85:136\u2013141. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.02.042","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR89","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jtho.2017.12.006","volume":"13","author":"TP Robin","year":"2018","unstructured":"Robin TP et al (2018) Excellent outcomes with radiosurgery for multiple brain metastases in ALK and EGFR driven non-small cell lung cancer. J Thorac Oncol 13:715\u2013720. https:\/\/doi.org\/10.1016\/j.jtho.2017.12.006","journal-title":"J Thorac Oncol"},{"key":"3152_CR90","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1148\/radiol.13131470","volume":"271","author":"JL Roh","year":"2014","unstructured":"Roh JL et al (2014) 18F fluorodeoxyglucose PET\/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Radiology 271:153\u2013161. https:\/\/doi.org\/10.1148\/radiol.13131470","journal-title":"Radiology"},{"key":"3152_CR91","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.ijrobp.2008.10.023","volume":"74","author":"KE Rusthoven","year":"2009","unstructured":"Rusthoven KE, Raben D, Schneider C, Witt R, Sammons S, Raben A (2009) Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. Int J Radiat Oncol Biol Phys 74:1365\u20131370. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR92","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ijrobp.2010.07.013","volume":"81","author":"H Rutten","year":"2011","unstructured":"Rutten H et al (2011) Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic. Int J Radiat Oncol Biol Phys 81:923\u2013929. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR93","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/COC.0b013e3181d270b4","volume":"34","author":"JC Rwigema","year":"2011","unstructured":"Rwigema JC et al (2011) Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol 34:63\u201369","journal-title":"Am J Clin Oncol"},{"key":"3152_CR94","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/neuonc\/nox001","volume":"19","author":"A Sahgal","year":"2017","unstructured":"Sahgal A, Ruschin M, Ma L, Verbakel W, Larson D, Brown PD (2017) Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues. Neuro-Oncology 19:2\u201315. https:\/\/doi.org\/10.1093\/neuonc\/nox001","journal-title":"Neuro-Oncology"},{"key":"3152_CR95","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3171\/2013.2.JNS121213","volume":"118","author":"DJ Salvetti","year":"2013","unstructured":"Salvetti DJ, Nagaraja TG, McNeill IT, Xu Z, Sheehan J (2013) Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article. J Neurosurg 118:1250\u20131257. https:\/\/doi.org\/10.3171\/2013.2.JNS121213","journal-title":"J Neurosurg"},{"key":"3152_CR96","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","volume":"373","author":"M Schaapveld","year":"2015","unstructured":"Schaapveld M et al (2015) Second cancer risk up to 40 years after treatment for Hodgkin's Lymphoma. N Engl J Med 373:2499\u20132511. https:\/\/doi.org\/10.1056\/NEJMoa1505949","journal-title":"N Engl J Med"},{"key":"3152_CR97","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ijrobp.2008.01.051","volume":"72","author":"D Schellenberg","year":"2008","unstructured":"Schellenberg D et al (2008) Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 72:678\u2013686. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.01.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR98","doi-asserted-by":"publisher","first-page":"e0172055","DOI":"10.1371\/journal.pone.0172055","volume":"12","author":"DL Schwartz","year":"2017","unstructured":"Schwartz DL et al (2017) SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial. PLoS ONE 12:e0172055. https:\/\/doi.org\/10.1371\/journal.pone.0172055","journal-title":"PLoS ONE"},{"key":"3152_CR99","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/annonc\/mdy522","volume":"30","author":"TY Seiwert","year":"2019","unstructured":"Seiwert TY et al (2019) OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Ann Oncol 30:297\u2013302. https:\/\/doi.org\/10.1093\/annonc\/mdy522","journal-title":"Ann Oncol"},{"key":"3152_CR100","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/PPO.0b013e3181ddd088","volume":"16","author":"AN Shoushtari","year":"2010","unstructured":"Shoushtari AN et al (2010) Clinical nodal staging of T1\u20132 tonsillar squamous cell carcinoma stratified by p16 status and implications for ipsilateral neck irradiation. Cancer J 16:284\u2013287. https:\/\/doi.org\/10.1097\/PPO.0b013e3181ddd088","journal-title":"Cancer J"},{"key":"3152_CR101","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1245\/s10434-018-6614-3","volume":"25","author":"MJ Silverstein","year":"2018","unstructured":"Silverstein MJ et al (2018) Intraoperative radiation therapy (IORT): a series of 1000 tumors. Ann Surg Oncol 25:2987\u20132993. https:\/\/doi.org\/10.1245\/s10434-018-6614-3","journal-title":"Ann Surg Oncol"},{"key":"3152_CR102","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.oraloncology.2016.08.013","volume":"61","author":"P Sinha","year":"2016","unstructured":"Sinha P, Pipkorn P, Thorstad WL, Gay HA, Haughey BH (2016) Does elimination of planned postoperative radiation to the primary bed in p16-positive, transorally-resected oropharyngeal carcinoma associate with poorer outcomes? Oral Oncol 61:127\u2013134. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.08.013","journal-title":"Oral Oncol"},{"key":"3152_CR103","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","volume":"8","author":"BD Smith","year":"2018","unstructured":"Smith BD et al (2018) Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol 8:145\u2013152. https:\/\/doi.org\/10.1016\/j.prro.2018.01.012","journal-title":"Pract Radiat Oncol"},{"key":"3152_CR104","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"R Soffietti","year":"2013","unstructured":"Soffietti R et al (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65\u201372. https:\/\/doi.org\/10.1200\/JCO.2011.41.0639","journal-title":"J Clin Oncol"},{"key":"3152_CR105","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/neuonc\/now241","volume":"19","author":"R Soffietti","year":"2017","unstructured":"Soffietti R et al (2017) Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro-oncology 19:162\u2013174. https:\/\/doi.org\/10.1093\/neuonc\/now241","journal-title":"Neuro-oncology"},{"key":"3152_CR106","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","volume":"89","author":"L Specht","year":"2014","unstructured":"Specht L et al (2014) Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys 89:854\u2013862. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.05.005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR107","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijrobp.2014.07.002","volume":"90","author":"PW Sperduto","year":"2014","unstructured":"Sperduto PW et al (2014) Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1\u20133 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys 90:526\u2013531. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR108","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/cancers2031565","volume":"2","author":"MC Stauder","year":"2010","unstructured":"Stauder MC, Miller RC (2010) stereotactic body radiation therapy (SBRT) for unresectable pancreatic carcinoma. Cancers 2:1565\u20131575. https:\/\/doi.org\/10.3390\/cancers2031565","journal-title":"Cancers"},{"key":"3152_CR109","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0140-6736(15)00471-7","volume":"387","author":"V Strnad","year":"2016","unstructured":"Strnad V et al (2016) 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. The Lancet 387:229\u2013238. https:\/\/doi.org\/10.1016\/s0140-6736(15)00471-7","journal-title":"The Lancet"},{"key":"3152_CR110","doi-asserted-by":"crossref","unstructured":"Studer G, Luetolf UM, Glanzmann C (2007) Locoregional failure analysis in head-and-neck cancer patients treated with IMRT Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al] 183:417\u2013423. doi:10.1007\/s00066\u2013007\u20131663\u20138 (discussion 424\u2013415)","DOI":"10.1007\/s00066-007-1663-8"},{"key":"3152_CR111","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0140-6736(10)60837-9","volume":"376","author":"JS Vaidya","year":"2010","unstructured":"Vaidya JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376:91\u2013102. https:\/\/doi.org\/10.1016\/S0140-6736(10)60837-9","journal-title":"Lancet"},{"key":"3152_CR112","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","volume":"383","author":"JS Vaidya","year":"2014","unstructured":"Vaidya JS et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT\u2014a randomised trial. Lancet 383:603\u2013613. https:\/\/doi.org\/10.1016\/S0140-6736(13)61950-9","journal-title":"Lancet"},{"key":"3152_CR113","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.radonc.2018.04.020","volume":"128","author":"S van den Bosch","year":"2018","unstructured":"van den Bosch S, Vogel WV, Raaijmakers CP, Dijkema T, Terhaard CHJ, Al-Mamgani A, Kaanders J (2018) Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation. Radiother Oncol 128:472\u2013478. https:\/\/doi.org\/10.1016\/j.radonc.2018.04.020","journal-title":"Radiother Oncol"},{"key":"3152_CR114","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1245\/ASO.2006.08.011","volume":"13","author":"GR Varadhachary","year":"2006","unstructured":"Varadhachary GR et al (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035\u20131046. https:\/\/doi.org\/10.1245\/ASO.2006.08.011","journal-title":"Ann Surg Oncol"},{"key":"3152_CR115","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ijrobp.2009.08.042","volume":"78","author":"MR Vergeer","year":"2010","unstructured":"Vergeer MR et al (2010) Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 78:682\u2013688. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.08.042","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR116","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","volume":"14","author":"U Veronesi","year":"2013","unstructured":"Veronesi U et al (2013) Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14:1269\u20131277. https:\/\/doi.org\/10.1016\/S1470-2045(13)70497-2","journal-title":"Lancet Oncol"},{"key":"3152_CR117","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/annonc\/mdw051","volume":"27","author":"VM Villaflor","year":"2016","unstructured":"Villaflor VM et al (2016) Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Ann Oncol 27:908\u2013913. https:\/\/doi.org\/10.1093\/annonc\/mdw051","journal-title":"Ann Oncol"},{"key":"3152_CR118","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ijrobp.2009.05.012","volume":"75","author":"DC Weber","year":"2009","unstructured":"Weber DC, Peguret N, Dipasquale G, Cozzi L (2009) Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study. Int J Radiat Oncol Biol Phys 75:1578\u20131586. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.05.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR119","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ijrobp.2010.05.035","volume":"81","author":"DC Weber","year":"2011","unstructured":"Weber DC, Johanson S, Peguret N, Cozzi L, Olsen DR (2011) Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients. Int J Radiat Oncol Biol Phys 81:490\u2013497. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.05.035","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3152_CR120","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513\u2013520. https:\/\/doi.org\/10.1056\/NEJMoa0906260","journal-title":"N Engl J Med"},{"key":"3152_CR121","doi-asserted-by":"publisher","first-page":"485071","DOI":"10.1155\/2015\/485071","volume":"2015","author":"M Witkowska","year":"2015","unstructured":"Witkowska M, Majchrzak A, Smolewski P (2015) The role of radiotherapy in Hodgkin's lymphoma: what has been achieved during the last 50 years? Biomed Res Int 2015:485071. https:\/\/doi.org\/10.1155\/2015\/485071","journal-title":"Biomed Res Int"},{"key":"3152_CR122","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1097\/MPA.0b013e318291fbc5","volume":"42","author":"M Worni","year":"2013","unstructured":"Worni M et al (2013) Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008. Pancreas 42:1157\u20131163. https:\/\/doi.org\/10.1097\/MPA.0b013e318291fbc5","journal-title":"Pancreas"},{"issue":"Suppl","key":"3152_CR123","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3171\/2014.8.GKS141421","volume":"121","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Watanabe S, Kasuya H (2014) Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2\u20139 versus 10 or more tumors. J Neurosurg 121(Suppl):16\u201325. https:\/\/doi.org\/10.3171\/2014.8.GKS141421","journal-title":"J Neurosurg"},{"key":"3152_CR124","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","volume":"15","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387\u2013395. https:\/\/doi.org\/10.1016\/S1470-2045(14)70061-0","journal-title":"Lancet Oncol"},{"key":"3152_CR125","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12149-007-0097-9","volume":"22","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki Y et al (2008) Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 22:177\u2013184. https:\/\/doi.org\/10.1007\/s12149-007-0097-9","journal-title":"Ann Nucl Med"},{"key":"3152_CR126","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3978\/j.issn.2304-3865.2015.03.05","volume":"4","author":"W Zhang","year":"2015","unstructured":"Zhang W (2015) Radiotherapy in early stage classical Hodgkin lymphoma: past, present and future. Chin Clin Oncol 4:6. https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2015.03.05","journal-title":"Chin Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03152-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-020-03152-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03152-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T08:39:38Z","timestamp":1613723978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-020-03152-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3152"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03152-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}